MarketCap
Facebook
X
TelegramQuarterly report 2025-Q4
added 02-09-2026
Country |
 USA |
IPO year |
- |
Industry |
Medical instruments |
Stock Exchange |
NYSESPB |
Shares |
288 M |
Market Cap[1] |
$ 44.4 B |
EBITDA (LTM) |
$ 4.45 B |
P/E (LTM) |
28.25 |
P/S (LTM) |
2.09 |
EPS (LTM) |
5.46 |
Becton, Dickinson and Company is an international company specializing in the development and production of medical devices and technologies for the diagnosis and treatment of various diseases. The company was founded in 1897 in the United States and today is one of the largest manufacturers of medical devices in the world.
BDX offers a wide range of medical devices, including syringes, needles, blood collection systems, microbiological and diagnostic systems, and more. The company also provides training for healthcare professionals, consultations, and support for patients.
The company has offices worldwide and serves patients in more than 190 countries. The headquarters are located in New Jersey, USA.
Becton, Dickinson and Company's goal is to help people lead healthy lifestyles by providing them with innovative medical devices and technologies. The company actively works on developing new products and improving the quality of its services to meet the needs of its customers.
Other stocks of industry "Medical instruments"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
 |
AtriCure
ATRC
|
$ 28.23 | 0.64 % | $ 1.35 B | Nasdaq Global Market,SPB | USA |
 |
Baxter International
BAX
|
$ 17.15 | -0.87 % | $ 8.8 B | NYSE,SPB | USA |
 |
Atrion Corporation
ATRI
|
- | - | $ 810 M | Nasdaq Global Select Market,SPB | USA |
 |
BioLife Solutions
BLFS
|
$ 19.74 | -3.61 % | $ 909 M | Nasdaq Global Select Market | USA |
 |
Luminex Corporation
LMNX
|
- | - | $ 1.75 B | Nasdaq Global Select Market | USA |
 |
Akers Biosciences, Inc.
AKER
|
- | -9.52 % | $ 20.6 M | Nasdaq Capital Market | USA |
 |
Alcon
ALC
|
$ 78.01 | 0.79 % | $ 40.4 B | NYSE |  Schweiz |
 |
Ekso Bionics Holdings
EKSO
|
- | - | $ 21.9 M | Nasdaq Capital Market | USA |
 |
The Cooper Companies
COO
|
$ 71.21 | -0.35 % | $ 14.2 B | NYSE,SPB | USA |
 |
Antares Pharma, Inc.
ATRS
|
- | - | $ 955 M | Nasdaq Capital Market | USA |
 |
Haemonetics Corporation
HAE
|
$ 57.32 | -1.88 % | $ 2.88 B | NYSE,SPB | USA |
 |
Cantel Medical Corp.
CMD
|
- | -1.18 % | $ 3.4 B | NYSE | USA |
 |
CRH Medical Corporation
CRHM
|
- | - | $ 282 M | NYSE American | USA |
 |
Hill-Rom Holdings, Inc.
HRC
|
- | -0.05 % | $ 10.3 B | NYSE,SPB | USA |
 |
Repro Med Systems
KRMD
|
$ 4.21 | -3.66 % | $ 194 M | Nasdaq Capital Market | USA |
 |
Varian Medical Systems, Inc.
VAR
|
- | -0.02 % | $ 16.3 B | NYSE | USA |
 |
Harvard Bioscience
HBIO
|
$ 4.31 | -19.74 % | $ 191 M | Nasdaq Global Market | USA |
 |
Microbot Medical
MBOT
|
$ 2.59 | 4.44 % | $ 119 M | Nasdaq Global Select Market |  Israel |
 |
electroCore
ECOR
|
$ 6.08 | -8.57 % | $ 51.6 K | Nasdaq Global Select Market | USA |
 |
Masimo Corporation
MASI
|
$ 178.32 | -0.01 % | $ 9.5 B | Nasdaq Global Select Market,SPB | USA |
 |
iRhythm Technologies
IRTC
|
- | - | $ 3.69 B | Nasdaq Global Select Market,SPB | USA |
 |
Isoray
ISR
|
- | 0.03 % | $ 108 M | NYSE American | USA |
 |
Milestone Scientific
MLSS
|
$ 0.28 | 0.81 % | $ 23 M | NYSE American | USA |
 |
Merit Medical Systems
MMSI
|
$ 68.26 | -0.57 % | $ 4.04 B | Nasdaq Global Select Market,SPB | USA |
 |
Glaukos Corporation
GKOS
|
$ 116.4 | -2.55 % | $ 5.64 B | NYSE,SPB | USA |
 |
ICU Medical
ICUI
|
$ 125.68 | -0.12 % | $ 3.1 B | Nasdaq Global Select Market,SPB | USA |
 |
InfuSystem Holdings
INFU
|
$ 9.38 | -2.49 % | $ 194 M | NYSE American | USA |
 |
Envista Holdings Corporation
NVST
|
$ 26.39 | -1.05 % | $ 4.43 B | NYSE | USA |
 |
Pro-Dex
PDEX
|
$ 51.48 | 1.2 % | $ 169 M | Nasdaq Global Select Market | USA |
 |
Intuitive Surgical
ISRG
|
- | - | $ 161 B | Nasdaq Global Select Market,SPB | USA |
 |
Predictive Oncology
POAI
|
- | - | $ 31.1 M | Nasdaq Capital Market | USA |
 |
LeMaitre Vascular
LMAT
|
$ 114.62 | 1.69 % | $ 2.59 B | Nasdaq Global Market,SPB | USA |
 |
ResMed
RMD
|
$ 228.87 | 0.39 % | $ 33.4 B | NYSE,SPB | USA |
 |
Retractable Technologies
RVP
|
$ 0.67 | -6.67 % | $ 20.1 M | NYSE American | USA |
 |
Pulse Biosciences
PLSE
|
$ 18.67 | -3.01 % | $ 1.26 B | Nasdaq Global Select Market | USA |
 |
STERIS plc
STE
|
$ 222.58 | -0.52 % | $ 21.9 B | NYSE,SPB | USA |
 |
Stereotaxis
STXS
|
$ 1.87 | -4.1 % | $ 170 M | NYSE American | USA |
 |
Teleflex Incorporated
TFX
|
$ 118.39 | -1.56 % | $ 5.28 B | NYSE,SPB | USA |
 |
STAAR Surgical Company
STAA
|
$ 26.44 | 4.88 % | $ 1.31 B | Nasdaq Global Market,SPB | USA |
 |
NeuroMetrix
NURO
|
- | 5.05 % | $ 9.02 M | Nasdaq Global Select Market | USA |
 |
Utah Medical Products
UTMD
|
$ 65.9 | 1.6 % | $ 214 M | Nasdaq Global Select Market | USA |
 |
DENTSPLY SIRONA
XRAY
|
$ 11.71 | -1.26 % | $ 2.33 B | Nasdaq Global Select Market,SPB | USA |
 |
West Pharmaceutical Services
WST
|
$ 256.55 | -0.77 % | $ 18.5 B | NYSE,SPB | USA |
 |
AngioDynamics
ANGO
|
$ 9.8 | -2.87 % | $ 400 M | Nasdaq Global Select Market | USA |
 |
Nephros
NEPH
|
$ 2.96 | 1.72 % | $ 30.7 M | Nasdaq Global Select Market | USA |
 |
OraSure Technologies
OSUR
|
$ 2.96 | -3.27 % | $ 218 M | Nasdaq Global Select Market,SPB | USA |
 |
Repligen Corporation
RGEN
|
$ 120.1 | 0.27 % | $ 6.69 M | Nasdaq Global Select Market,SPB | USA |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.